<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949723/" ref="ordinalpos=3947&amp;ncbi_uid=2506482&amp;link_uid=PMC2949723" image-link="/pmc/articles/PMC2949723/figure/F3/" class="imagepopup">Figure 3.  From: Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping. </a></div><br /><div class="p4l_captionBody"><b>The eicosanoid signaling pathway from Ingenuity Pathway Analysis software</b>. Only part of the pathway is shown. The highlighted genes (in yellow) were down-regulated in the 4 day CFA model of inflammatory pain. PLA2: phospholipase A2 group IVA; PTGS: prostaglandin-endoperoxide synthase 1; ALOX12, ALOX15: rat arachidonate 12/15-lipoxygenase.</div></div>